Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125276072 | 12527607 | 2 | F | 2016 | 20160830 | 20160705 | 20160830 | PER | US-SHIRE-US201607043 | SHIRE | 63.21 | YR | F | Y | 90.25000 | KG | 20160830 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125276072 | 12527607 | 1 | PS | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 1 | Oral | 50 MG, 1X/DAY:QD | 21977 | 50 | MG | CAPSULE | QD | ||||||
| 125276072 | 12527607 | 2 | SS | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 20 MG, 1X/DAY:QD | 0 | 20 | MG | TABLET | QD | ||||||
| 125276072 | 12527607 | 3 | C | LOSARTAN. | LOSARTAN | 1 | Oral | 50 MG, 1X/DAY:QD | 0 | 50 | MG | TABLET | QD | ||||||
| 125276072 | 12527607 | 4 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Oral | 40 MG, 1X/DAY:QD | 0 | 40 | MG | QD | |||||||
| 125276072 | 12527607 | 5 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | Oral | 81 MG, 1X/DAY:QD | 0 | 81 | MG | TABLET | QD | ||||||
| 125276072 | 12527607 | 6 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Oral | 5000 MG, 1X/DAY:QD | 0 | 5000 | MG | SUBLINGUAL TABLET | QD | ||||||
| 125276072 | 12527607 | 7 | C | FERRO-SEQUELS | 2 | Oral | 50 MG, 1X/DAY:QD | 0 | 50 | MG | SUBLINGUAL TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125276072 | 12527607 | 1 | Binge eating |
| 125276072 | 12527607 | 2 | Sleep disorder |
| 125276072 | 12527607 | 3 | Hypertension |
| 125276072 | 12527607 | 4 | Blood triglycerides increased |
| 125276072 | 12527607 | 5 | Anticoagulant therapy |
| 125276072 | 12527607 | 6 | Haemolytic anaemia |
| 125276072 | 12527607 | 7 | Haemolytic anaemia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125276072 | 12527607 | Condition aggravated | |
| 125276072 | 12527607 | Drug ineffective | |
| 125276072 | 12527607 | Product quality issue | |
| 125276072 | 12527607 | Therapeutic response unexpected | |
| 125276072 | 12527607 | Weight decreased | |
| 125276072 | 12527607 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125276072 | 12527607 | 1 | 20160525 | 0 | ||
| 125276072 | 12527607 | 2 | 201601 | 0 | ||
| 125276072 | 12527607 | 3 | 2014 | 0 | ||
| 125276072 | 12527607 | 4 | 2005 | 0 | ||
| 125276072 | 12527607 | 5 | 2005 | 0 | ||
| 125276072 | 12527607 | 6 | 2014 | 0 | ||
| 125276072 | 12527607 | 7 | 2014 | 0 |